In the field of Consumer Healthcare, we have products for four general categories: Wellness, Oral Hygiene, Skin Health and Nutrition.
We contribute to the Greek economy and we employ 287 people in Pharma, Vaccines and Consumer Health divisions.
We take initiatives that assist the activities of the state and the National Healthcare System, in addition to improving patients’ living and supporting the actions of their healthcare professionals.
We closely collaborate with the healthcare professionals who provide us with scientific and medical insights as well as specialised advice on patients’ care, while due to our commitment to corporate social responsibility, we support vulnerable social groups and collaborate with patient advocacy groups, supporting their actions.
Our values and expectations are at the core of our activities, enabling us to deliver our mission which is to help people do more, feel better and live longer.
Pharmaceuticals and Vaccines
Address:
GlaxoSmithKline Single Member Commercial and Industrial Societe Anonyme of Pharmaceutical Products
266 Kifissias Avenue
Halandri
Athens
Greece
15232
Tel:
Fax:
Reporting an adverse event related to a GSK product
Tel:
+302106882100 (24-hour line)
Reporting a product complaint related to a GSK product
Requesting information related to a GSK product
Tel:
+302106882100 (24-hour line)
Privacy contact information
For further information please click here
Customer services
Consumer Healthcare
Address:
GlaxoSmithKline Consumer Healthcare Single Member SA
274 Kifissias Avenue
Chalandri
Athens
Greece
15232
Tel:
0080044144381 (no charge)
+30210 6882100
Reporting an adverse event related to a GSK product
Tel:
+302106882100 (24-hour line)
Customer services or any other help
General media enquiries
Healthcare professionals
Health professionals in Greece can obtain information about products and areas of therapy related to GSK by visiting GSKPro
Transfer of Value Disclosure in Greece based on EFPIA Disclosure Code
Since 2005, we implement the Code of Practice for interacting with patient groups, which focuses on ensuring patient groups' independence, mutual respect and transparency. The basic principles of the code are applied by the entire pharmaceutical industry with the adoption of the Code of the European Federation of Pharmaceutical Industries and Associations (EFPIA), which has been adopted by the Hellenic Association of Pharmaceutical Companies (SFEE).
Under GSK’s code, which defines our company's partnerships with patient associations, we publish every year data on the financial support per association and per project, while financial support to patient advocacy organisations cannot exceed the 25% of the annual total funding in order to ensure their independence.
Useful links:
- Patient Advocacy Group Support in Greece for 2018 - 2021
PDF - 251KB - Methodological Note for 2021
PDF - 98KB
